Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.

Eishingdrelo H, Kongsamut S

DOI: 10.2174/2213988501307010009
Published: 2013
Container: Current chemical genomics and translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/2213988501307010009,
  title = {Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.},
  author = {Eishingdrelo H and Kongsamut S},
  year = {2013},
  journal = {Current chemical genomics and translational medicine},
  doi = {10.2174/2213988501307010009},
  url = {https://doi.org/10.2174/2213988501307010009}
}

RIS

TY  - JOUR
TI  - Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.
AU  - Eishingdrelo H
AU  - Kongsamut S
PY  - 2013
JO  - Current chemical genomics and translational medicine
DO  - 10.2174/2213988501307010009
UR  - https://doi.org/10.2174/2213988501307010009
ER  -

APA

H, E., & S, K. (2013). Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.. Current chemical genomics and translational medicine. https://doi.org/10.2174/2213988501307010009

Source records

pubmed · retrieved 2026-09-26T12:07:11.269Z